IAI CONFERENCE: The influence of extracts and fractions from matoa leaves (Pometia pinnata) on angiotensin I levels
DOI:
https://doi.org/10.46542/pe.2021.212.168171Keywords:
Angiotensin I levels, Ethanol extract, Fraction, Induced angiotensin II, Pometia pinnataAbstract
Introduction: The matoa plant (Pometia pinnata) leaves can be used to treat hypertension. Matoa leaves are thought to have antihypertensive activity because they contain flavonoids. These flavonoids can reduce blood pressure that is modulated by the renin-angiotensin-aldosterone system (RAAS). It is suspected that matoa leaves have antihypertensive activity as they contain quercetin which is a compound that is presumed to be an angiotensin-converting enzyme (ACE) inhibitor.
Aims: This study aims to determine which extracts and fractions from matoa leaves are able to decrease angiotensin I levels.
Methods: The extraction was done by maceration with 96% ethanol solvent and fractionated by a liquid method using an n-hexane fraction solvent, an ethyl acetate fraction, and a water fraction. In this study, 21 male Wistar rats were used as test animals and divided into seven groups: Group I was the normal control, group II was the negative control (CMC-Na 1%), group III was the positive control (Irbesartan), group IV was given matoa leaf extract with 60 mg/200g body weight ratio, Group V was given 2.34 mg/g fraction of n-hexane, Group VI was given ethyl acetate fraction 9.54 mg/200g ethyl acetate fraction, and Group VII was given water fraction 7.98 mg/200g water fraction. The data obtained was analysed using the Shapiro-Wilk test, the Levene test, and analysis of variance (ANOVA).
Results: The results showed that the angiotensin I levels induced by angiotensin II were more significant (p < 0,05) than those in the normal and negative groups. The ethyl acetate fraction showed a 23.6% decrease in angiotensin I level, which was close to the 24.8% decrease in the positive group. The extract from the matoa leaves showed a 17.2% decrease in angiotensin I levels which were close to the 20% decrease in the positive group.
References
Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, and Posey LM. (2017). Pharmacotherapy a pathophysiologic approach, 10th ed New York: McGraw Hill. 45-78.
Elisa. N. (2019). Antihypertensive activity test of extracts and leaf fractions of matoa (Pometia pinnata JR Forster & JG. Forster) in male rats induced by angiotensin II using blood pressure parameters and cardiac muscle cell image.
Kumar et al. (2014). Enthancement of solubility and disolution rate of irbesartan by solid dispersion thechnique. Journal of Pharmaceutical and Clinical Research (9), 0974-2441.
Larson AJ, Symons JD, Jalili T. (2010). Quercetin: A treatment for hypertension. Pharmaceuticals,; 3(1), 237-250. https://doi.org/10.3390/ph3010237
Park SE et al. (2014). Induction of apoptosis in MDA-MB human breast carcinoma cells with an ethanol extract of cyperus rotundus L. by activating caspases: 5-6 https://doi.org/10.3892/or.2014.3507
Purwidyaningrum I, Sukandar EY, Fidrianny. (2017). Antihypertensive activity of extract and fractions of matoa (Pometia pinnata J. R & G Forts) Leaves. Asian J Pharm Clin Res, 10(3), 323-328. https://doi.org/10.22159/ajpcr.2017.v10i3.16221
Riskesda. (2018) Health Research and Development Agency, Ministry of Basic Health, 88-94
Suedee A, Tewtrakul S, and Panichayupakaranant P. (2013). Anti-HIV-1 integrase compound from Pometia pinnata leaves, Pharmaceutical Biology, 51(10), 1256-1261. https://doi.org/10.3109/13880209.2013.786098
World Health Organization. (2012). Managing for Rational Medicine Use. Geneva
